Radiopharm Theranostics (ASX:RAD, Nasdaq: RADX, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, today announced that members of management will be participating in the D. Boral Capital Inaugural Global Conference on May 14, 2025, in New York…
Cardiex Limited (CDX:AU) has announced Lodgement of CONNEQT Pulse Device with the TGA Download the PDF here. This post…
AngloGold Ashanti (NYSE:AU,JSE:ANG)has agreed to sell its interests in two Côte d’Ivoire gold projects to Resolute Mining (ASX:RSG,LSE:RSG) as…
White Cliff Minerals Limited (“WCN” or the “Company”) (ASX: WCN; OTCQB: WCMLF) is pleased to announce further assay results…
Warren Buffett has a formidable reputation as an investor — with a net worth of US$160 billion in May…
The energy revolution is here to stay, and electric vehicles (EVs) have become part of the mainstream narrative. The…
General Motors’ (GM) (NYSE:GM) decision to cut a third shift at its Oshawa, Ontario, assembly plant this fall has…
Brightstar Resources (BTR:AU) has announced RIU Conference Presentation Download the PDF here. This post appeared first on investingnews.com